CN110111906A - A kind of drug monitoring device and drug storage device - Google Patents
A kind of drug monitoring device and drug storage device Download PDFInfo
- Publication number
- CN110111906A CN110111906A CN201810065555.2A CN201810065555A CN110111906A CN 110111906 A CN110111906 A CN 110111906A CN 201810065555 A CN201810065555 A CN 201810065555A CN 110111906 A CN110111906 A CN 110111906A
- Authority
- CN
- China
- Prior art keywords
- drug
- module
- environmental information
- monitoring
- monitoring device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 160
- 229940079593 drug Drugs 0.000 title claims abstract description 129
- 238000012806 monitoring device Methods 0.000 title claims abstract description 30
- 238000012545 processing Methods 0.000 claims abstract description 35
- 230000007613 environmental effect Effects 0.000 claims abstract description 32
- 238000012544 monitoring process Methods 0.000 claims abstract description 32
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 39
- 102000004877 Insulin Human genes 0.000 claims description 21
- 108090001061 Insulin Proteins 0.000 claims description 21
- 229940125396 insulin Drugs 0.000 claims description 19
- 238000004891 communication Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 229920002527 Glycogen Polymers 0.000 description 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000003538 oral antidiabetic agent Substances 0.000 description 2
- 229940127209 oral hypoglycaemic agent Drugs 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 206010061666 Autonomic neuropathy Diseases 0.000 description 1
- 208000001380 Diabetic Ketoacidosis Diseases 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 102000016261 Long-Acting Insulin Human genes 0.000 description 1
- 108010092217 Long-Acting Insulin Proteins 0.000 description 1
- 229940100066 Long-acting insulin Drugs 0.000 description 1
- 108010067035 Pancrelipase Proteins 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000004121 glycogenesis Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000002727 hyperosmolar Effects 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 230000004140 ketosis Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 231100001028 renal lesion Toxicity 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- G06F19/30—
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The present invention relates to a kind of drug monitoring device and drug storage devices, and wherein drug monitoring device includes: input module, for inputting the shelf-life of drug and the corresponding relationship of environmental information；Monitoring modular, for monitoring the environmental information of storage drug；Processing module, according to the corresponding relationship of shelf-life and environmental information that the resulting environmental information of monitoring module monitors and input module input, processing show that drug is stored in the corresponding shelf-life under the resulting environmental information of monitoring；Output module, for exporting, monitoring modular detects resulting environmental information and processing module handles resulting result.Drug monitoring device provided by the present invention can provide more accurately information for user, such as, in the case where being limited by certain external conditions and drug can not be made to be stored in its preferred temperature range, so that user knows the shelf-life corresponding to drug storage at such a temperature, and then user still can use the drug safe and securely within the shelf-life.
Description
Technical field
The present invention relates to a kind of monitoring devices, more particularly to a kind of drug monitoring device and drug storage device.
Background technique
Diabetes are one group of metabolic diseases characterized by hyperglycemia, are that China's disease incidence is high, endanger serious prevalence
One of disease.Long-standing hyperglycemia when diabetes, cause various tissues, especially eye, kidney, heart, blood vessel, nerve it is chronic
Damage, dysfunction, cause various diabetic complications.
According to the urgency of diabetic complication morbidity is slow and difference pathologically, it is big that acute and chronic two can be classified as
Class:
(1) the Diabetic Acute complication cause of disease: including diabetic ketoacidosis, Hyperglycemic hyperosmolar status, lactate acid
Poisoning etc., pathogenic factor mainly since insulin active severe lacks and the inappropriate raising of glycemic hormone, lead to blood glucose mistake
Height, and cause sugar, fat and protein metabolism disorder, so that body water, electrolyte and acid-base imbalance.
(2) the chronic complicating diseases of diabetes cause of disease: chronic complicating diseases are the main reason for diabetes disable, is lethal, main to wrap
It includes: 1. macrovascular complications, such as the lesion of the cerebrovascular, angiocarpy and lower limb vascular；2. microvascular complication, such as renal lesions
And eyeground pathological changes；3. neuropathy, the sensory nerve including being responsible for sense organ dominate the kinesitherapy nerve of body movement, and department's reason
Internal organ, blood vessel and autonomic neuropathy of endocrine function etc..
Therefore, the treatment of diabetes is particularly important.Diabetes can be divided into two types: type 1 diabetes and 2 types
Diabetes.And at present for treating the diabetes of both types, insulin all occupies highly important status, especially
For type 1 diabetes.
Type 1 diabetes: nonreinforcement curer injects 2~3 insulin daily, and intensive treatment person injects 3~4 pancreases daily
Island element, or use insulin pump in treatment；Diabetes B: oral hypoglycemic agents failure person first uses combination therapy mode, and method is original
It is constant with orally-taken blood sugar reducing pharmaceutical quantities, it sleeps the evening before yesterday 10: 00 and injects intermediate-acting insulins or Recent Development of Long-acting Insulin Analogs, generally every 3 days
Adjustment 1 time, nonresponder deactivates oral hypoglycemic agents, is changed to inject 2 insulin daily.
The utilization that insulin (Regular insulin) can increase glucose, accelerates the anerobic glycolysis of glucose and has
Oxygen oxidation, promote hepatic glycogen and muscle glycogen synthesis and storage, and can promote convert glucose for fat, control decomposition of glycogen and
Gluconeogenesis, thus blood glucose can be made to reduce.In addition, it can also promote the synthesis of fat, inhibits lipolysis, subtract ketoplasia
It is few, correct the various symptoms of ketosis acidaemia.
Therefore, also seem most important for the good preservation of insulin.
Patent document 1 (CN 206120761U) discloses a kind of for timed reminding and/or the medicine of emergency alert function
Box, including shell, medicine storehouse, alarm set and control circuit, in which: the medicine storehouse includes multiple daily medicine storehouses and urgent medicine
Storehouse, each medicine storehouse are an independent medicinal box, include that medicine storehouse indicator light and medicine storehouse open and close sensor in medicinal box；The prompting
Device, setting on the shell, for issuing light and/or auditory tone cues, remind timing medication and/or emergency alarm；The control
Circuit is electrically connected with alarm set, medicine storehouse indicator light, medicine storehouse folding sensor, for monitoring the folding shape in each medicine storehouse
State, and corresponding instruction is issued by the indicator light in each medicine storehouse.
It takes auxiliary/urgent positioning etc. however, although the medicine box realizes medication alert/medication monitoring/urgent drug and is
Column function, but whether it can not remind user's drug expired.
Patent document 2 (CN 107229235A) discloses a kind of intelligent medicine box, including intelligent medicine box cabinet, intelligent medicine box
Box house has multiple for the medicine storage unit of automatic vending and the multilayer medicine storage unit of homebrew；In intelligent medicine box cabinet
It is provided with mainboard, also sets up display screen, human-computer interaction key and electronic lock thereon；It is arranged in warehouse door outside medicine storage unit
Electronic lock；Mainboard has central control chip, and central control chip connects display screen, human-computer interaction key and electronic lock.Into
One step, the intelligent medicine box cabinet is divided into two parts, forms the multilayer medicine storage unit of homebrew in the lower end of medicine storage unit；
The intelligent medicine box cabinet also has Dehumidifying element, refrigeration unit, Temperature Humidity Sensor；Time, temperature and humidity are shown by display screen
Value, supplements situation with money at goods information.
However, although the medicine-chest has Dehumidifying element, refrigeration unit, Temperature Humidity Sensor, so that the temperature of medicine-chest saves
In a certain range, but it can not provide drug and be stored under a certain specific environment, such as at a certain temperature, corresponding guarantor
The matter phase.In the case where being limited by certain external conditions and drug can not be made to be stored in its preferred temperature, user just can not know
Know the shelf-life corresponding to drug storage at such a temperature.
Therefore it provides more accurately drug monitoring device becomes this medical field even domestic environments urgently to a kind of information
It needs.
Summary of the invention
To solve the above-mentioned problems, the purpose of the present invention is to provide a kind of information more accurately drug monitoring devices.
The present invention provides a kind of drug monitoring devices, comprising: input module, for inputting shelf-life and the environment of drug
The corresponding relationship of information；Monitoring modular, for monitoring the environmental information of storage drug；Processing module, according to monitoring module monitors
The corresponding relationship of the shelf-life and environmental information of resulting environmental information and input module input, processing show that drug is stored in prison
Survey the corresponding shelf-life under resulting environmental information；Output module, for export monitoring modular detect resulting environmental information and
The resulting result of processing module processing.
Further, input module is also used to input the date of manufacture of drug, and processing module is inputted according to input module
The resulting environment letter of the corresponding relationship and monitoring module monitors of the date of manufacture of drug and the shelf-life of drug and environmental information
Breath, processing obtain the validity date of drug.
It further, further include time module, for obtaining real-time Perfect Time, when validity date≤Perfect Time,
Output module exports prompting message.
Further, input module is also used to input the total amount and each usage amount of drug, and monitoring modular is also used to monitor
The access times of drug, the total amount and each usage amount and monitoring modular for the drug that processing module is inputted according to input module are supervised
Resulting access times are surveyed, processing obtains the surplus of drug.
Further, input module is also used to input the prompting threshold value of the surplus of drug, when processing module processing gained
Surplus≤surplus prompting threshold value, output module export prompting message.
Further, prompting message includes voice reminder information and/or non-voice prompting message.
Further, environmental information includes at least one of environment temperature, ambient humidity and vibrations parameter；Drug is pancreas
Island element.
Further, output module further includes wireless communication module, and wireless communication module is used to processing module handling institute
The result obtained is sent to external equipment.
It further, further include temperature control modules, temperature control modules are used to control storage drug according to preset instructions
Environment temperature be pre-set constant value.
The present invention also provides a kind of drug storage devices, comprising: above-mentioned drug monitoring device；One or more chambers
Room, for storing drug.
As above, drug monitoring device provided by the present invention can provide more accurately information for user, for example, by
To certain external conditions limitation and drug can not be made to be stored under its preferred temperature range so that user know the drug store up
In the presence of the shelf-life corresponding at this temperature, and then user still can use the drug safe and securely within the shelf-life.
For above content of the invention can be clearer and more comprehensible, preferred embodiment is cited below particularly, and in conjunction with attached drawing, make detailed
It is described as follows.
Detailed description of the invention
Below in conjunction with attached drawing, specific embodiments of the present invention will be described in further detail.
Fig. 1 is the drug monitoring device that one embodiment of the invention provides；
Fig. 2 be another embodiment of the present invention provides drug monitoring device.
Specific embodiment
Embodiments of the present invention are illustrated by particular specific embodiment below, those skilled in the art can be by this specification
Revealed content is understood other advantages and efficacy of the present invention easily.Although description of the invention will combine preferred embodiment
It introduces together, but this feature for not representing the invention is only limitted to the embodiment.On the contrary, being invented in conjunction with embodiment
The purpose of introduction is to be possible to the other selections extended or transformation to cover based on claim of the invention.In order to mention
For that will include many concrete details in depth understanding of the invention, being described below.The present invention can also be thin without using these
Section is implemented.In addition, in order to avoid confusion or obscuring emphasis of the invention, some details will be omitted in the de-scription.
Referring to FIG. 1, the present invention provides a kind of drug monitoring devices 1, comprising: input module 10, monitoring modular 20, place
Manage module 30 and output module 40.Wherein, input module 10 is used to input the shelf-life of drug and the corresponding relationship of environmental information；
Monitoring modular 20 is used to monitor the environmental information of storage drug；Processing module 30 monitors resulting environment according to monitoring modular 20
The corresponding relationship of shelf-life and environmental information that information and input module 10 input, it is resulting that processing show that drug is stored in monitoring
The corresponding shelf-life under environmental information；Output module 40 detects resulting environmental information and processing mould for exporting monitoring modular 20
Block 30 handles resulting result.
Drug monitoring device 1 provided by the present invention can provide more accurately information for user, for example, even if by
The limitation of certain external conditions and when drug can not be made to be stored within the scope of its preferred temperature, user also understand that the drug
Shelf-life corresponding to storage at such a temperature, and then user still can use the medicine safe and securely within the shelf-life
Object.In addition, only providing the shelf-life when drug is stored within the scope of its preferred temperature, user in general drug specification
When can not learn that drug is stored in the preferred range under a certain actual temp, corresponding to shelf-life.Therefore, this hair
Drug monitoring device 1 provided by bright by providing more accurately information for user, thus improve user to the shelf-life can
It is handling.User can be by the adjustment to drug storage temperature, and then can suitably extend its shelf-life, in turn, ensures that simultaneously
The drug remains to be used in not rotten/effective situation, while improving drug shelf-life controllability, also ensures
The safety that drug uses.
In this embodiment, drug is insulin.Because environment temperature is to influence the principal element that insulin is rotten or fails, because
This in this embodiment, environmental information is environment temperature.But in other embodiments, drug is also possible to the medicine in addition to insulin
Object；In addition, due to when medicament storage is when the big environment of humidity, drug strenuous vibration or drug are in vibrating state for a long time,
Also it is easy inactivation, goes bad, so the environmental information can also include mainly influencing the drug such as ambient humidity, vibrations parameter
Rotten or failure information, wherein vibrations parameter specifically includes shockproofness and vibration frequency.User can be according to different medicines
Object determines the environmental information for mainly influencing that the drug is rotten or fails, and then in input module 10, inputs guaranteeing the quality for the drug
The corresponding relationship of phase and environmental information.
Wherein, input module 10 is also used to input the date of manufacture of insulin, and processing module 30 can be according to monitoring modular
The shelf-life for the insulin that the resulting environment temperature of 20 monitorings, input module 10 input and the corresponding relationship of environment temperature, obtain
The shelf-life of corresponding insulin at this ambient temperature, further according to input module 10 input insulin date of manufacture, into
And obtain the validity date of insulin under the environment temperature.At this point, input module 10 will handle resulting validity date export to
User.
Referring to FIG. 2, in the above-described embodiments, drug monitoring device 1 can also include time module 50, for obtaining reality
When Perfect Time, when validity date≤Perfect Time, output module 40 exports prompting message, and user's insulin is reminded to surpass
The shelf-life has been spent, there is rotten or failure security risk, new insulin should be bought again to be replaced.Alternatively, user
The time threshold that a prompting can also be set by input module 10, when time threshold≤Perfect Time, output module 40
Just prompting message is exported, reminds user to carry out timely drug and buys, replacement is i.e. by expired drug.
In the above-described embodiments, input module 10 is also used to input the total amount and each usage amount of drug.Wherein, mould is monitored
Block 20 is also used to monitor the access times of drug, the total amount for the drug that processing module 30 is inputted according to input module 10 and makes every time
Dosage and monitoring modular 20 monitor resulting access times, and processing obtains the surplus of drug.
In the above-described embodiments, input module 10 is also used to input the prompting threshold value of the surplus of drug, works as processing module
The prompting threshold value of the 30 resulting surplus≤surpluses of processing, output module 40 export prompting message, user are reminded to carry out drug
Timely supply.
For example, such as the total amount of one bottle of drug is 3ml, and each usage amount is 0.1ml, and monitoring modular 20 monitors this
For drug because having been taken out needed for using 3 times, processing module 30, which can be handled, show that the surplus of drug is 2.7ml.If setting
Surplus prompting threshold value be 1ml, then output module 40 will export prompting message to mention after user has used 20 times
Awake user feeds drug in time.
Further, output module 40 can also include wireless communication module, and wireless communication module is used for processing module
The 30 resulting results of processing are sent to external equipment.Specifically, external equipment can be the tool such as computer, mobile phone, tablet computer
There is mobile terminal.Output module 40 is by wireless communication module, and output monitoring modular 20 monitors resulting environment temperature, in the prison
Surveying the shelf-life and term of validity of insulin and prompting message under resulting environment temperature reminds user to make drug purchase in time
Or supply.Preferably, the case where external equipment is mobile phone, and user can check in real time by cell phone application or monitor drug.
Wherein, prompting message includes voice reminder information and/or non-voice prompting message, and wherein voice reminder information includes
The tinkle of bells or voice；Non-voice prompting message includes one of color, text, pattern or a variety of.Further, the present embodiment
In, when drug inactivation, rotten or expired, when output module 40 exports prompting message, to guarantee drug safety, can set must
The prompting message must could be eliminated by way of replacing drug, otherwise the display alarm information always of output module 40, to remind
The inactivation of user's drug, rotten or outdated information.
Further, Fig. 2 is referred to, drug test device provided by the invention further includes temperature control modules 60, the temperature
Spending control module 60 to be used to control the environment temperature of storage drug according to preset instructions is pre-set constant value.Specifically, in drug
Actual storage environment in, when being limited by certain external conditions and drug can not be made to be stored at its preferred temperature,
Drug often go bad because of low temperature or high temperature, and the drug storage device in the present embodiment passes through temperature control modules 60 can be with
The environment temperature for storing drug is controlled in pre-set pre-set constant value, which, which specifically can be, passes through input
Module is inputted by user or manufacturer, and the size of the pre-set constant value can be specifically arranged according to actual storage drug, this implementation
Example is not specifically limited in this embodiment.Further, which can be the trigger action instruction of pre-set user, can also
To be that the environmental information detected according to detection module 20 triggers its corresponding preset instructions, controls the temperature control modules 60 and exist
After receiving the preset instructions, the environment temperature for storing drug is controlled in pre-set constant value.
The present invention also provides a kind of drug storage devices, including above-mentioned drug monitoring device 1 and chamber.Wherein, chamber
Room can be one or more, for storing drug.The drug storage device passes through drug monitoring device 1, and then can be to one
Or total medication amount of multiple indoor drugs of chamber is monitored.
In conclusion provided by the invention, the above-described embodiments merely illustrate the principles and effects of the present invention, rather than
For limiting the present invention.Any person skilled in the art all without departing from the spirit and scope of the present invention, to above-mentioned reality
It applies example and carries out modifications and changes.Therefore, such as those of ordinary skill in the art without departing from disclosed
Spirit with technical idea under all equivalent modifications or change for being completed, should be covered by the claims of the present invention.
Claims (10)
1. a kind of drug monitoring device characterized by comprising
Input module, for inputting the shelf-life of drug and the corresponding relationship of environmental information；
Monitoring modular, for monitoring the environmental information for storing the drug；
Processing module, the shelf-life inputted according to the resulting environmental information of the monitoring module monitors and the input module
With the corresponding relationship of environmental information, processing show that the drug is stored in corresponding under the resulting environmental information of monitoring guarantee the quality
Phase；
Output module, for exporting, monitoring modular detects resulting environmental information and the processing module handles resulting result.
2. drug monitoring device according to claim 1, which is characterized in that the input module is also used to input the medicine
The date of manufacture of object, date of manufacture of the drug that the processing module is inputted according to the input module and the drug
The corresponding relationship and the resulting environmental information of the monitoring module monitors of shelf-life and environmental information, processing obtain the medicine
The validity date of object.
3. drug monitoring device according to claim 2, which is characterized in that further include time module, for obtaining in real time
Perfect Time, when the validity date≤Perfect Time, the output module exports prompting message.
4. drug monitoring device according to claim 1, which is characterized in that the input module is also used to input the medicine
The total amount of object and each usage amount, the monitoring modular are also used to monitor the access times of the drug, the processing module root
According to the total amount of the drug of input module input and each usage amount and the resulting use of the monitoring module monitors
Number, processing obtain the surplus of the drug.
5. drug monitoring device according to claim 4, which is characterized in that the input module is also used to input the medicine
The prompting threshold value of the surplus of object, when the processing module handles resulting surplus≤surplus prompting threshold value, institute
State output module output prompting message.
6. the drug monitoring device according to claim 3 or 5, which is characterized in that the prompting message includes voice reminder
Information and/or non-voice prompting message.
7. drug monitoring device according to any one of claims 1-5, which is characterized in that the environmental information includes ring
At least one of border temperature, ambient humidity and vibrations parameter；The drug is insulin.
8. drug monitoring device according to any one of claims 1-5, which is characterized in that the output module further includes
Wireless communication module, the wireless communication module are used to the resulting result of processing module processing being sent to external equipment.
9. drug monitoring device according to any one of claims 1-5, which is characterized in that further include temperature control mould
Block, the temperature control modules are used to according to the environment temperature that preset instructions control stores the drug be pre-set constant value.
10. a kind of drug storage device characterized by comprising
Drug monitoring device according to any one of claims 1 to 5；
One or more chambers, for storing the drug.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810065555.2A CN110111906A (en) | 2018-01-23 | 2018-01-23 | A kind of drug monitoring device and drug storage device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810065555.2A CN110111906A (en) | 2018-01-23 | 2018-01-23 | A kind of drug monitoring device and drug storage device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110111906A true CN110111906A (en) | 2019-08-09 |
Family
ID=67483480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810065555.2A Pending CN110111906A (en) | 2018-01-23 | 2018-01-23 | A kind of drug monitoring device and drug storage device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110111906A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112330134A (en) * | 2020-10-29 | 2021-02-05 | 北京奇禹科技有限公司 | Method and system for detecting quality guarantee state of article |
| CN113439731A (en) * | 2021-07-23 | 2021-09-28 | 北京百瑞弘霖有害生物防治科技有限责任公司 | Pesticide application monitoring method, device and system |
| CN113551475A (en) * | 2020-04-23 | 2021-10-26 | 青岛海尔智能技术研发有限公司 | Method, device and equipment for medicine preservation |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101055255A (en) * | 2006-04-10 | 2007-10-17 | 张恒涛 | Enzyme type time-temperature indication card production method |
| CN103322765A (en) * | 2012-03-23 | 2013-09-25 | 海尔集团公司 | Refrigerator with article quality guarantee information prompting function |
| CN105055173A (en) * | 2015-08-14 | 2015-11-18 | 菲力克斯电子（宁波）有限公司 | Intelligent medical kit |
| CN105708707A (en) * | 2016-03-15 | 2016-06-29 | 王丽 | Method for prompting patient to accurately take medicine based on novel medicine chest |
| CN105721556A (en) * | 2016-01-25 | 2016-06-29 | 上海斐讯数据通信技术有限公司 | Family medicine management terminal, system and method |
| CN105915358A (en) * | 2016-05-31 | 2016-08-31 | 青岛海尔股份有限公司 | Data transmission method and system of refrigerator |
| DE102015105997A1 (en) * | 2015-04-20 | 2016-10-20 | Iblue Ag | Storage device for monitoring a product to be monitored, its use and a method for monitoring a product |
| CN206523246U (en) * | 2017-01-05 | 2017-09-26 | 刘楠 | A kind of intelligent shelf-life label |
| CN207925143U (en) * | 2018-01-23 | 2018-09-28 | 袁丽 | A kind of drug monitoring device and drug storage device |
-
2018
- 2018-01-23 CN CN201810065555.2A patent/CN110111906A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101055255A (en) * | 2006-04-10 | 2007-10-17 | 张恒涛 | Enzyme type time-temperature indication card production method |
| CN103322765A (en) * | 2012-03-23 | 2013-09-25 | 海尔集团公司 | Refrigerator with article quality guarantee information prompting function |
| DE102015105997A1 (en) * | 2015-04-20 | 2016-10-20 | Iblue Ag | Storage device for monitoring a product to be monitored, its use and a method for monitoring a product |
| CN105055173A (en) * | 2015-08-14 | 2015-11-18 | 菲力克斯电子（宁波）有限公司 | Intelligent medical kit |
| CN105721556A (en) * | 2016-01-25 | 2016-06-29 | 上海斐讯数据通信技术有限公司 | Family medicine management terminal, system and method |
| CN105708707A (en) * | 2016-03-15 | 2016-06-29 | 王丽 | Method for prompting patient to accurately take medicine based on novel medicine chest |
| CN105915358A (en) * | 2016-05-31 | 2016-08-31 | 青岛海尔股份有限公司 | Data transmission method and system of refrigerator |
| CN206523246U (en) * | 2017-01-05 | 2017-09-26 | 刘楠 | A kind of intelligent shelf-life label |
| CN207925143U (en) * | 2018-01-23 | 2018-09-28 | 袁丽 | A kind of drug monitoring device and drug storage device |
Non-Patent Citations (1)
| Title |
|---|
| 国家食品药品监督管理局执业药师资格认证中心: "《国家职业药师资格考试指南：药学综合知识与技能》", vol. 1, 中国医药科学出版社, pages: 322 - 323 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113551475A (en) * | 2020-04-23 | 2021-10-26 | 青岛海尔智能技术研发有限公司 | Method, device and equipment for medicine preservation |
| CN112330134A (en) * | 2020-10-29 | 2021-02-05 | 北京奇禹科技有限公司 | Method and system for detecting quality guarantee state of article |
| WO2022089099A1 (en) * | 2020-10-29 | 2022-05-05 | 北京奇禹科技有限公司 | Article quality assurance status checking method and system |
| CN112330134B (en) * | 2020-10-29 | 2024-05-31 | 北京奇禹科技有限公司 | Object quality assurance state detection method and detection system |
| CN113439731A (en) * | 2021-07-23 | 2021-09-28 | 北京百瑞弘霖有害生物防治科技有限责任公司 | Pesticide application monitoring method, device and system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110675949B (en) | Drug injection and disease management systems, devices and methods | |
| US10369281B2 (en) | Devices, systems and methods for adjusting fluid delivery parameters | |
| TWI639131B (en) | Method and system for management of diabetes with a glucose monitor and infusion pump to provide feedback on bolus dosing | |
| EP2309917B1 (en) | Device that for interactively managing a treatment for glycemic level control in a diabetic patient | |
| IL304414B1 (en) | Therapy assist information and/or tracking device and related methods and systems | |
| JP2018516151A (en) | Monitoring device for drug application with a drug pen type injector with log recording function, communication function and alarm | |
| AU2010233418B2 (en) | System and method for monitoring pulmonary congestion | |
| CN107135644A (en) | Decision support for diabetic | |
| KR20100028054A (en) | Therapy delivery system having an open architecture and a method thereof | |
| WO2008124478A1 (en) | Systems, methods, and computer program product for improved management of medical procedures for patients on medical protocols | |
| CN110111906A (en) | A kind of drug monitoring device and drug storage device | |
| JP2021511925A (en) | Monitoring device with a general-purpose adapter to a drug pen injector | |
| CN106174985B (en) | Intelligent medicine box | |
| CN113643820A (en) | Early warning information generation method and device, computer equipment and storage medium | |
| CN207925143U (en) | A kind of drug monitoring device and drug storage device | |
| CA3145377C (en) | Automatic drug delivery system for delivery of a glp-1 therapeutic | |
| CN115132373A (en) | Analgesic administration adjusting method, device, terminal, system and readable storage medium | |
| EP1534210B1 (en) | Signalling device to make the administering of medical preparations easier | |
| US20250127993A1 (en) | Automated medicament delivery system adjustments when taking a pharmaceutical | |
| US20230405224A1 (en) | Autonomous dose determination for pen delivery of medicament | |
| JP7712211B2 (en) | Adaptive Care Management System | |
| TWM531849U (en) | Portable insulin injection assistance kit | |
| KR100662732B1 (en) | Diabetes Treatment Guidelines System | |
| WO2024157126A1 (en) | Valid message interval for patient messaging inbox | |
| CN117379654A (en) | Closed loop anesthesia control apparatus, method, system, and medium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190809 |
|
| RJ01 | Rejection of invention patent application after publication |